drugset / Trial / NCT05187546
Test-retest Study With [18F]PI-2620 in PSP-RS and NDC
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The overall goal of this protocol is to evaluate the imaging characteristics of \[18F\]PI-2620 using positron emission tomography (PET) in patients with progressive supranuclear palsy, Richardson's syndrome (PSP-RS)
Timeline
- Start
- 2022-03-10
- Primary completion
- 2024-02-29
- Completion
- 2024-03-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]PI-2620 | Diagnostic / imaging agent | 185 mbq | — |